SCHEMBL1276209

SCHEMBL1276209

CCCCCC(CC)(CC)Oc1ccccc1O.CCOc1ccccc1-c1ccnnn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.36
CNR2 P34972 4/20 0.36
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
KCNN4 O15554 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP19A1 P11511 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDE5A O76074 3/20 0.30
PDE4A P27815 2/20 0.30
PDE4B Q07343 2/20 0.30
PDE4C Q08493 2/20 0.30
PDE4D Q08499 2/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30
TLR4 O00206 1/20 0.30
TLR3 O15455 1/20 0.30
TLR5 O60602 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64303 0.92 CNR1 (0.45) CNR1CNR2MEN1POLBKMT2A
Guaiacol SCHEMBL29291132 0.91 CNR1 (0.44) CNR1CNR2MEN1POLBKMT2A
SCHEMBL28914891 0.91 CNR1 (0.44) CNR1CNR2MEN1POLBKMT2A
SCHEMBL491257 0.90 CNR1 (0.36) CNR1CNR2MEN1KMT2ACYP1A2
SCHEMBL1372006 0.88 CNR1 (0.35) CNR1CNR2CYP1A2CYP19A1CYP2C9
SCHEMBL1722938 0.85 LMNA (0.34) CNR1CNR2CYP1A2CYP19A1CYP2C9
SCHEMBL28576458 0.84 CNR1 (0.33) CNR1CNR2CYP1A2CYP19A1CYP2C9
SCHEMBL3793515 0.82 PDE5A (0.35) CNR1CNR2KCNN4CYP1A2CYP19A1
SCHEMBL16167433 0.82 CNR1 (0.39) CNR1CNR2MEN1POLBKMT2A
SCHEMBL28235565 0.81 PPARA (0.39) CNR1CNR2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3236913-A1 COSMETIC SUNSCREEN COMPOSITION Spirig Pharma AG (CH) 2017-11-01 EP disclosed
EP-3223777-A1 COSMETIC COMPOSITION COMPRISING A SYNTHETIC PHYLLOSILICATE AND A POLYOL AND/OR A UV FILTER L'Oréal (FR) 2017-10-04 EP disclosed
WO-2016102064-A1 COSMETIC SUNSCREEN COMPOSITION SPIRIG PHARMA AG (CH) 2016-06-30 WO disclosed
WO-2016083404-A1 COSMETIC COMPOSITION COMPRISING A SYNTHETIC PHYLLOSILICATE AND A POLYOL AND/OR A UV FILTER L'OREAL (FR) 2016-06-02 WO disclosed
EP-2745831-B1 Cosmetic emulsion with silica dimethyl silylate BEIERSDORF AG (DE) 2015-08-12 EP disclosed
WO-2012104262-A1 PHOTORESPONSIVE MICROCAPSULES AND COMPOSITIONS CONTAINING SAME UNIVERSIDAD DE SEVILLA (ES) 2012-08-09 WO disclosed
EP-2467122-A2 PHOTORESPONSIVE SUNSCREEN COMPOSITION Blueshift Pharma GmbH (CH) 2012-06-27 EP disclosed
US-20120148647-A1 Photoresponsive Sunscreen Composition BLUESHIFT PHARMA GMBH (CH) 2012-06-14 US disclosed
WO-2011020928-A2 PHOTORESPONSIVE SUNSCREEN COMPOSITION BLUESHIFT PHARMA GMBH (CH) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120148647-A1 Photoresponsive Sunscreen Composition SUN2, MC1R, MITF CNR1 4591/4885CNR2 4341/4885MEN1 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.